PT2197456E - Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico - Google Patents

Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico Download PDF

Info

Publication number
PT2197456E
PT2197456E PT08835989T PT08835989T PT2197456E PT 2197456 E PT2197456 E PT 2197456E PT 08835989 T PT08835989 T PT 08835989T PT 08835989 T PT08835989 T PT 08835989T PT 2197456 E PT2197456 E PT 2197456E
Authority
PT
Portugal
Prior art keywords
hyaluronic acid
combination
tamarind seed
compositions based
seed polysaccharide
Prior art date
Application number
PT08835989T
Other languages
English (en)
Inventor
Antonio Del Prete
Marco Sanso
Original Assignee
Hmfra Hungary Korl Tolt Felel Ss G T Rsas G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hmfra Hungary Korl Tolt Felel Ss G T Rsas G filed Critical Hmfra Hungary Korl Tolt Felel Ss G T Rsas G
Publication of PT2197456E publication Critical patent/PT2197456E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT08835989T 2007-10-02 2008-10-02 Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico PT2197456E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.

Publications (1)

Publication Number Publication Date
PT2197456E true PT2197456E (pt) 2011-05-18

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08835989T PT2197456E (pt) 2007-10-02 2008-10-02 Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico

Country Status (14)

Country Link
US (1) US8455462B2 (pt)
EP (1) EP2197456B1 (pt)
JP (1) JP5542674B2 (pt)
KR (1) KR101570966B1 (pt)
AT (1) ATE499106T1 (pt)
CA (1) CA2701721C (pt)
DE (1) DE602008005173D1 (pt)
ES (1) ES2361529T3 (pt)
IT (1) ITRM20070510A1 (pt)
MX (1) MX2010003488A (pt)
PL (1) PL2197456T3 (pt)
PT (1) PT2197456E (pt)
RU (1) RU2493855C2 (pt)
WO (1) WO2009044423A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE429209T1 (de) * 2005-02-09 2009-05-15 Safilens S R L Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
JP2013526594A (ja) * 2010-05-24 2013-06-24 インデナ エッセ ピ ア 微生物感染の治療に使用するためのタマリンド種子多糖
ES2635169T3 (es) * 2010-05-24 2017-10-02 Indena S.P.A. Polisacárido de semillas de tamarindo y extracto de Ferula hermonis para uso en el tratamiento de enfermedades inflamatorias
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
US20170027980A1 (en) 2014-04-15 2017-02-02 Novintethical Pharma Sa Composition based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
ES2705692T3 (es) 2015-06-11 2019-03-26 Novintethical Pharma Sa Composiciones nasales tópicas que contienen xiloglucanos para usar como descongestionantes
SG10201913468YA (en) * 2015-07-13 2020-03-30 Tohoku Techno Arch Co Ltd Composition for optic nerve protection
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
US10702578B2 (en) * 2017-08-02 2020-07-07 Shilpa Medicare Limited Ophthalmic compositions of cyclosporine
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
CN112423723B (zh) * 2018-07-18 2024-03-08 阿特戈20有限责任公司 包含甘草甜素的组合物及其美容和制药用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
DE69833000T2 (de) * 1997-09-26 2006-09-07 Noven Pharmaceuticals, Inc., Miami Bio-klebemittelzusammensetzungen
ES2226203T3 (es) * 1998-12-23 2005-03-16 Idea Ag Formulacion mejorada para aplicacion topica no invasiva.
WO2005039619A1 (en) * 2003-10-03 2005-05-06 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
ATE429209T1 (de) 2005-02-09 2009-05-15 Safilens S R L Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法

Also Published As

Publication number Publication date
WO2009044423A1 (en) 2009-04-09
ITRM20070510A1 (it) 2009-04-03
US20100279981A1 (en) 2010-11-04
ATE499106T1 (de) 2011-03-15
KR20100091151A (ko) 2010-08-18
DE602008005173D1 (de) 2011-04-07
RU2010117173A (ru) 2011-11-10
JP2010540619A (ja) 2010-12-24
CA2701721A1 (en) 2009-04-09
RU2493855C2 (ru) 2013-09-27
ES2361529T3 (es) 2011-06-17
EP2197456A1 (en) 2010-06-23
CA2701721C (en) 2016-02-23
JP5542674B2 (ja) 2014-07-09
MX2010003488A (es) 2010-08-31
US8455462B2 (en) 2013-06-04
KR101570966B1 (ko) 2015-11-23
EP2197456B1 (en) 2011-02-23
PL2197456T3 (pl) 2012-07-31

Similar Documents

Publication Publication Date Title
PT2197456E (pt) Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
IN2012DN03632A (pt)
JP2010540619A5 (pt)
MX2010004834A (es) Composiciones de analogos de prostaglandina y metodos para tratar las condiciones relacionadas al epitelio.
MX2019000586A (es) Virus adenoasociados (aav) sflt-1 para usarse en el tratamiento de degeneración macular relacionada con la edad (amd).
BRPI0519508A2 (pt) análogos de aminopirazina para tratamento de glaucoma e outras doenças ou condições mediadas por rho cinase
MX345494B (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, dosificación farmacéutica de la misma, procesos para su preparación y usos de la misma para el control glucemico mejorado en un paciente.
MX2009004467A (es) Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
WO2009024677A3 (fr) Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses
MX2011014025A (es) Composicion farmaceutica que comprende sales de rotigotina (acidio o na), especialmente para iontoforesis.
WO2009102467A3 (en) Devices, formulations, and methods for delivery of multiple beneficial agents
TW200733964A (en) (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating rho kinase-mediated diseases and conditions
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
MX2010002210A (es) Derivados de catecolamina y profarmacos de los mismos.
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
MY150250A (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
TNSN06293A1 (en) Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose
WO2011087548A3 (en) Therapeutic compositions and methods for targeted delivery of active agents
IN2015DN02751A (pt)
UA95224C2 (ru) Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
NO20081035L (no) Ikke-invasivt legemiddel-leveringssystem som anvender en fast sammensetning pa vevet i bakre segment av oyet
MX2010003594A (es) Formas cristalinas de sal sodica de dmxaa.